Results 1 to 10 of about 181,406 (214)

Discovery and characterization of novel Aspergillus fumigatus mycoviruses. [PDF]

PLoS ONE, 2018
In the last few years, increasing numbers of viruses infecting fungi have been identified. In this study, we used an in silico approach for the analysis of deep RNA sequencing data in order to discover and characterize putative genomic ssRNA or dsRNA ...
Jan Zoll, Paul E Verweij, Willem J G Melchers   +2 more
doaj   +2 more sources

Environmental Hotspots for Azole Resistance Selection of Aspergillus fumigatus, the Netherlands

Emerging Infectious Diseases, 2019
Azole resistance is a major concern for treatment of infections with Aspergillus fumigatus. Environmental resistance selection is a main route for Aspergillus spp. to acquire azole resistance.
Sijmen E. Schoustra, Alfons J.M. Debets, Antonius J.M.M. Rijs, Jianhua Zhang, Eveline Snelders, Peter C. Leendertse, Willem J.G. Melchers, Anton G. Rietveld, Bas J. Zwaan, Paul E. Verweij   +9 more
doaj   +2 more sources

<i>Aspergillus fumigatus</i> spondylitis in an immunocompetent patient with annular high signal around the intervertebral disks: a case report and literature review. [PDF]

Front Med (Lausanne)
Aspergillus fumigatus spondylitis is a rare fungal infection, primarily occurring in immunocompromised patients, although cases in immunocompetent individuals have also been reported.
Xu Z, Zhu W, Zhou S, Zhao Y, Xiang Q, Zhang Y.   +5 more
europepmc   +2 more sources

Aspergillus fumigatus-Related Species in Clinical Practice

Frontiers in Microbiology, 2016
Aspergillus fumigatus is the main etiologic agent of invasive aspergillosis (IA). Other Aspergillus species belonging to the section Fumigati (A. fumigatus complex) may occasionally be the cause of IA.
Frederic eLamoth
doaj   +2 more sources

Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment

Nature Microbiology, 2022
Infections caused by the fungal pathogen Aspergillus fumigatus are increasingly resistant to first-line azole antifungal drugs. However, despite its clinical importance, little is known about how susceptible patients acquire infection from drug-resistant
J. Rhodes, A. Abdolrasouli, Katie Dunne, Thomas R. Sewell, Yu-yun Zhang, Eloise Ballard, A. Brackin, N. van Rhijn, H. Chown, Alexandra Tsitsopoulou, R. Posso, S. H. Chotirmall, N. McElvaney, P. Murphy, A. F. Talento, J. Renwick, P. Dyer, A. Székely, P. Bowyer, M. Bromley, Elizabeth M. Johnson, P. Lewis White, A. Warris, R. Barton, S. Schelenz, T. Rogers, D. Armstrong-James, M. Fisher   +27 more
semanticscholar   +1 more source

Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance

PLoS Pathogens, 2021
Aspergillus fumigatus is an opportunistic human pathogen that causes aspergillosis, a spectrum of environmentally acquired respiratory illnesses. It has a cosmopolitan distribution and exists in the environment as a saprotroph on decaying plant matter ...
C. Burks, Alexandria Darby, Luisa Gómez Londoño, M. Momany, M. Brewer   +4 more
semanticscholar   +1 more source

Aspergillus fumigatus

Case Studies in Infectious Disease, 2020
This datasheet on Aspergillus fumigatus covers Identity, Distribution, Hosts/Species Affected, Further Information.
Peter M. Lydyard, Michael F. Cole, John Holton, William L. Irving, Nino Porakishvili, Pradhib Venkatesan, K. Ward   +6 more
semanticscholar   +2 more sources

Validity of Platelia Aspergillus IgG and Aspergillus Precipitin Test To Distinguish Pulmonary Aspergillosis from Colonization

Microbiology Spectrum, 2023
When Aspergillus, an ubiquitous, saprophytic fungus, is detected in respiratory tract specimens collected from chronic respiratory disease patients, it is important to determine whether it is a true infection or colonization.
Kyota Shinfuku, Junko Suzuki, Keita Takeda, Masahiro Kawashima, Yoshiteru Morio, Yuka Sasaki, Hideaki Nagai, Akira Watanabe, Hirotoshi Matsui, Katsuhiko Kamei   +9 more
doaj   +1 more source

A 20-Year Antifungal Susceptibility Surveillance (From 1999 to 2019) for Aspergillus spp. and Proposed Epidemiological Cutoff Values for Aspergillus fumigatus and Aspergillus flavus: A Study in a Tertiary Hospital in China

Frontiers in Microbiology, 2021
The emergence of resistant Aspergillus spp. is increasing worldwide. Long-term susceptibility surveillance for clinically isolated Aspergillus spp. strains is warranted for understanding the dynamic change in susceptibility and monitoring the emergence ...
Xinyu Yang, Xinyu Yang, Xinyu Yang, Xinyu Yang, Wei Chen, Wei Chen, Wei Chen, Wei Chen, Tianyu Liang, Tianyu Liang, Tianyu Liang, Tianyu Liang, JingWen Tan, JingWen Tan, JingWen Tan, JingWen Tan, Weixia Liu, Weixia Liu, Weixia Liu, Weixia Liu, Yi Sun, Yi Sun, Yi Sun, Yi Sun, Qian Wang, Qian Wang, Qian Wang, Qian Wang, Hui Xu, Hui Xu, Hui Xu, Hui Xu, Lijuan Li, Lijuan Li, Lijuan Li, Lijuan Li, Yabin Zhou, Yabin Zhou, Yabin Zhou, Yabin Zhou, Qiqi Wang, Qiqi Wang, Qiqi Wang, Qiqi Wang, Zhe Wan, Zhe Wan, Zhe Wan, Zhe Wan, Yinggai Song, Yinggai Song, Yinggai Song, Yinggai Song, Ruoyu Li, Ruoyu Li, Ruoyu Li, Ruoyu Li, Wei Liu, Wei Liu, Wei Liu, Wei Liu   +59 more
doaj   +1 more source

The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus

Nature Communications, 2020
The frequency of antifungal resistance, particularly to the azole class of ergosterol biosynthetic inhibitors, is a growing global health problem. Survival rates for those infected with resistant isolates are exceptionally low. Beyond modification of the
Takanori Furukawa, N. van Rhijn, M. Fraczek, F. Gsaller, Emma Davies, P. Carr, S. Gago, Rachael Fortune-Grant, Sayema Rahman, J. Gilsenan, E. Houlder, Caitlin H. Kowalski, Shriya Raj, S. Paul, P. Cook, J. Parker, S. Kelly, R. Cramer, J. Latgé, S. Moye-Rowley, E. Bignell, P. Bowyer, M. Bromley   +22 more
semanticscholar   +1 more source